Release Date: 13/12/18 14:18 Summary: RMS: Fifth Supplementary Bidder's Statement Price Sensitive: Yes Download Document Not available as of the moment. Download
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial